| Literature DB >> 10888787 |
C H Dunphy1, L J Gardner, C S Bee.
Abstract
The activation marker CD3O is useful in the diagnosis of Hodgkin and non-Hodgkin lymphomas. It has also been described in nonhematopoietic tumors, including pancreatic carcinomas, salivary gland tumors, and embryonal carcinomas. We report a case of malignant mesothelioma with intense CD30 positivity. This finding has not previously been described and is important in broadening the differential diagnosis of a CD30(+) cohesive large cell malignancy.Entities:
Mesh：
Substances：
Year: 2000 PMID： 10888787 DOI： 10.5858/2000-124-1077-MMWCP
Source DB: PubMed Journal: Arch Pathol Lab Med ISSN： 0003-9985 Impact factor: 5.534